{"product_id":"the-surgery-that-isnt-better-than-a-fake-one-what-a-landmark-knee-meniscus-trial-means-for-patients","title":"The Surgery That Isn't Better Than a Fake One: What a Landmark Knee Meniscus Trial Means for Patients","description":"\u003cp\u003eIn a landmark Finnish study published in the \u003cem\u003eNew England Journal of Medicine\u003c\/em\u003e, researchers set out to answer a controversial question: does arthroscopic partial meniscectomy—one of the most common orthopedic surgeries in the world—actually work better than doing nothing at all? The answer, based on 146 patients followed for 12 months, was a definitive no. Patients who received the real surgery improved just as much as those who received sham surgery (a simulated procedure where no actual tissue was removed), with no meaningful differences in knee pain, function, or quality of life. This suggests that for many patients with degenerative meniscal tears but no osteoarthritis, the relief they experience after arthroscopy may come from factors other than the removal of torn meniscal tissue.\u003c\/p\u003e\n\n\u003ch1\u003eThe Surgery That Isn't Better Than a Fake One: What a Landmark Knee Meniscus Trial Means for Patients\u003c\/h1\u003e\n\n\u003ch2\u003eTable of Contents\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ddn-key-points\"\u003eKey Points\u003c\/a\u003e\u003c\/li\u003e\n\n  \u003cli\u003e\u003ca href=\"#background\"\u003eBackground: Why This Research Matters\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#study-design\"\u003eStudy Design and Methods: How the Research Was Conducted\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#participants\"\u003eThe Participants: Who Was Included and Why\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#procedures\"\u003eThe Surgical Procedures: Real vs. Sham\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#outcomes\"\u003eOutcome Measures: What the Researchers Tracked\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#key-findings\"\u003eKey Findings: The Results at 12 Months\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#secondary-outcomes\"\u003eSecondary Outcomes and Safety Results\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#subgroup\"\u003eSubgroup Analyses: Did Any Group Benefit?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#limitations\"\u003eStudy Limitations: What This Study Couldn't Prove\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#clinical-implications\"\u003eClinical Implications: What This Means for Patients\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#recommendations\"\u003eRecommendations: What Patients Should Consider\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#ddn-faq\"\u003eFrequently Asked Questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#source\"\u003eSource Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ddn:keypoints:start --\u003e\n\u003ch2 id=\"ddn-key-points\"\u003eKey Points\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eIn a Finnish trial, 146 patients with degenerative meniscal tears but no osteoarthritis were randomized to real or sham arthroscopic partial meniscectomy.\u003c\/li\u003e\n\u003cli\u003eAt 12 months, real surgery was no better than sham surgery for knee pain, function, or quality of life; both groups improved similarly.\u003c\/li\u003e\n\u003cli\u003eThe trial was double-blind and sham-controlled, and every patient completed 12 months of follow-up.\u003c\/li\u003e\n\u003cli\u003eThese findings apply to degenerative tears in patients aged 35–65 without osteoarthritis, not to acute traumatic tears or mechanically locked knees.\u003c\/li\u003e\n\u003cli\u003eStructured exercise, physical therapy, and pain management produced equal outcomes in the trial, supporting conservative treatment as a first-line option.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- ddn:keypoints:end --\u003e\n\n\n\u003ch2 id=\"background\"\u003eBackground: Why This Research Matters\u003c\/h2\u003e\n\n\u003cp\u003eArthroscopic partial meniscectomy is the most common orthopedic procedure performed in the United States. Approximately \u003cstrong\u003e700,000 of these surgeries are done every year in the U.S. alone\u003c\/strong\u003e, with estimated annual direct medical costs of \u003cstrong\u003e$4 billion\u003c\/strong\u003e. The procedure involves inserting a small camera (arthroscope) into the knee through tiny incisions and using miniature instruments to remove torn fragments of the meniscus—the C-shaped cartilage that acts as a shock absorber between the thighbone and shinbone.\u003c\/p\u003e\n\n\u003cp\u003eThe surgery is designed to relieve symptoms by removing torn meniscal fragments and trimming the meniscus back to a stable rim. But here is the problem: \u003cstrong\u003emost meniscal tears treated with this surgery are degenerative\u003c\/strong\u003e, meaning they are related to wear-and-tear aging of the knee rather than a sudden injury. These tears often occur alongside degenerative knee disease, which can range from mild cartilage changes invisible on X-ray to full-blown osteoarthritis.\u003c\/p\u003e\n\n\u003cp\u003eThe number of arthroscopic surgeries performed for established knee osteoarthritis has decreased dramatically over the past 15 years, largely thanks to two controlled trials showing the surgery does not help those patients. Yet paradoxically, the number of arthroscopic partial meniscectomies has \u003cstrong\u003eincreased by 50% during the same period\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eA prior randomized trial had shown that arthroscopic partial meniscectomy combined with physical therapy provides no better symptom relief than physical therapy alone in patients who have a meniscal tear \u003cem\u003ewith\u003c\/em\u003e knee osteoarthritis. But until this study, no rigorous sham-controlled trial had examined whether the surgery helps patients who have a degenerative meniscal tear \u003cem\u003ewithout\u003c\/em\u003e osteoarthritis. The Finnish Degenerative Meniscal Lesion Study (FIDELITY) Group set out to fill that gap.\u003c\/p\u003e\n\n\u003ch2 id=\"study-design\"\u003eStudy Design and Methods: How the Research Was Conducted\u003c\/h2\u003e\n\n\u003cp\u003eThis was a \u003cstrong\u003emulticenter, randomized, double-blind, sham-controlled trial\u003c\/strong\u003e conducted at five orthopedic clinics in Finland between December 2007 and January 2013. The study was registered at ClinicalTrials.gov (number NCT00549172) and funded by the Sigrid Juselius Foundation and other organizations.\u003c\/p\u003e\n\n\u003cp\u003eLet's break down what those terms mean for patients:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRandomized:\u003c\/strong\u003e Patients were assigned to one of two groups by chance, like flipping a coin—but using a computer-generated sequence. This helps ensure the two groups are comparable.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDouble-blind:\u003c\/strong\u003e Neither the patients nor the researchers evaluating them knew who received the real surgery and who received the sham. The orthopedic surgeon in the operating room was the only one who knew.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSham-controlled:\u003c\/strong\u003e Half the patients received the actual arthroscopic partial meniscectomy, while the other half received a simulated (fake) version of the same surgery—identical in every way except no meniscal tissue was actually removed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe randomization was performed in a 1:1 ratio with a block size of 4 (known only to the statistician), and patients were stratified according to study site, age (35 to 50 or 51 to 65 years), sex, and whether they had minor degenerative changes on X-ray (Kellgren–Lawrence grade 0 or 1). The sequentially numbered, opaque, sealed envelopes containing group assignments were prepared by a statistician with no involvement in patient care.\u003c\/p\u003e\n\n\u003cp\u003ePatients were fully informed before joining the study that they might receive sham surgery. They were also told that if they did not get adequate symptom relief, they would be allowed to cross over to receive the real arthroscopic partial meniscectomy 6 months or later after the sham procedure. This was an important ethical safeguard.\u003c\/p\u003e\n\n\u003ch2 id=\"participants\"\u003eThe Participants: Who Was Included and Why\u003c\/h2\u003e\n\n\u003cp\u003eResearchers screened \u003cstrong\u003e205 patients\u003c\/strong\u003e for possible inclusion. Of these, \u003cstrong\u003e45 were excluded before arthroscopy\u003c\/strong\u003e for the following reasons:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e24 declined to participate\u003c\/li\u003e\n  \u003cli\u003e1 did not meet anesthesiologic outpatient criteria\u003c\/li\u003e\n  \u003cli\u003e18 became asymptomatic while waiting for surgery\u003c\/li\u003e\n  \u003cli\u003e2 had onset of episodes of a locked knee\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThat left \u003cstrong\u003e160 patients\u003c\/strong\u003e who underwent diagnostic knee arthroscopy. During that procedure, \u003cstrong\u003e14 more patients were excluded\u003c\/strong\u003e because of findings the surgeons discovered:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e6 did not actually have a tear in the medial meniscus\u003c\/li\u003e\n  \u003cli\u003e1 had an additional tear in the lateral meniscus\u003c\/li\u003e\n  \u003cli\u003e3 had a major chondral (cartilage) flap\u003c\/li\u003e\n  \u003cli\u003e2 needed meniscal repair instead of removal\u003c\/li\u003e\n  \u003cli\u003e2 underwent osteochondral microfracture (a different procedure)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eUltimately, \u003cstrong\u003e146 patients were randomized\u003c\/strong\u003e: 70 to the arthroscopic partial meniscectomy group and 76 to the sham-surgery group. Notably, there was \u003cstrong\u003ezero loss to follow-up\u003c\/strong\u003e—every single patient completed the 12-month assessment.\u003c\/p\u003e\n\n\u003cp\u003eTo be eligible, patients had to be between \u003cstrong\u003e35 and 65 years of age\u003c\/strong\u003e, have knee pain lasting more than 3 months that did not respond to conventional conservative treatment, and have clinical findings consistent with a tear of the medial meniscus. Patients with an obvious traumatic onset of symptoms or with knee osteoarthritis were excluded. Osteoarthritis was defined using clinical criteria from the American College of Rheumatology or radiographic criteria of Kellgren–Lawrence grade greater than 1. Preoperative MRI was used to confirm the meniscal tear, but final eligibility was determined by direct arthroscopic inspection.\u003c\/p\u003e\n\n\u003cp\u003eThe two groups were remarkably similar at the start of the trial. Both had an average age of \u003cstrong\u003e52 years\u003c\/strong\u003e. The meniscectomy group was 60% male, while the sham group was 62% male. Average body-mass index (BMI) was 26.9 in the surgery group and 27.9 in the sham group—both in the overweight range. The median duration of knee pain was \u003cstrong\u003e10 months in both groups\u003c\/strong\u003e. About half of each group had Kellgren–Lawrence grade 0 (no degenerative changes on X-ray), and the other half had grade 1 (minor degenerative changes such as doubtful joint-space narrowing or possible bone spurs).\u003c\/p\u003e\n\n\u003ch2 id=\"procedures\"\u003eThe Surgical Procedures: Real vs. Sham\u003c\/h2\u003e\n\n\u003cp\u003eFirst, all patients underwent diagnostic arthroscopy of the knee using standard portals and a 4-mm arthroscope. The surgeon examined the medial, lateral, and patellofemoral joint compartments. Only if the patient was confirmed to be eligible at this point did the randomization envelope get opened.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIn the real surgery (arthroscopic partial meniscectomy):\u003c\/strong\u003e The surgeon removed the damaged and loose parts of the meniscus using a mechanized shaver and meniscal punches until solid meniscal tissue was reached. The meniscus was then probed to make sure all loose and weak fragments and unstable meniscus had been successfully resected, while preserving as much healthy meniscus as possible. No other surgical procedures were performed.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIn the sham surgery:\u003c\/strong\u003e The procedure was designed to be indistinguishable from the real thing. To mimic the sensations and sounds of a true arthroscopic partial meniscectomy, the surgeon:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eAsked for all instruments (so the patient and staff would hear the normal requests)\u003c\/li\u003e\n  \u003cli\u003eManipulated the knee as if the surgery were being performed\u003c\/li\u003e\n  \u003cli\u003ePushed a mechanized shaver (without the blade) firmly against the patella—outside the knee\u003c\/li\u003e\n  \u003cli\u003eUsed suction to create the familiar sounds\u003c\/li\u003e\n  \u003cli\u003eKept the patient in the operating room for the same amount of time a real procedure would take\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eNo medication was instilled into the knee during either procedure. All procedures were standardized and recorded on video. Postoperative care was identical for both groups: all patients received the same walking aids, instructions, and a graduated exercise program, and were told to take over-the-counter pain relievers as needed. Importantly, the operating room staff who knew the group assignment did not participate in any further treatment or follow-up of the patient.\u003c\/p\u003e\n\n\u003ch2 id=\"outcomes\"\u003eOutcome Measures: What the Researchers Tracked\u003c\/h2\u003e\n\n\u003cp\u003eThe study had \u003cstrong\u003ethree primary outcomes\u003c\/strong\u003e, all measured 12 months after the procedure:\u003c\/p\u003e\n\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLysholm knee score:\u003c\/strong\u003e A validated, condition-specific questionnaire (8 items) that evaluates knee function and symptoms in daily living activities. Scores range from 0 (most severe symptoms) to 100 (no symptoms).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWestern Ontario Meniscal Evaluation Tool (WOMET) score:\u003c\/strong\u003e A meniscus-specific health-related quality-of-life instrument with 16 items covering three domains—physical symptoms (9 items), sports\/recreation\/work\/lifestyle disabilities (4 items), and emotions (3 items). Scores range from 0 to 100, with higher scores meaning better quality of life. This measure was added as a third primary outcome after it was validated for patients with degenerative meniscal tears, but before any data analysis.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eKnee pain after exercise:\u003c\/strong\u003e Rated on an 11-point scale from 0 (no pain) to 10 (extreme pain), referring to pain during the preceding week.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eSecondary outcomes included knee pain after exercise and Lysholm and WOMET scores at 2 and 6 months; knee pain at rest at 12 months; and the \u003cstrong\u003e15D score\u003c\/strong\u003e, a generic health-related quality-of-life instrument with 15 dimensions scored from 0 (death) to 1 (full health), also measured at 12 months.\u003c\/p\u003e\n\n\u003cp\u003eQuestionnaires were administered at baseline and at 2, 6, and 12 months after surgery. The follow-up questionnaires also tracked adverse events—any untoward medical occurrence, whether or not it was related to the treatment. Serious adverse events were defined as those requiring hospitalization, prolonging inpatient care, being life-threatening, or resulting in death.\u003c\/p\u003e\n\n\u003cp\u003eAt 12 months, patients answered four additional questions: Is your knee better than before the intervention? Are you satisfied with your knee at present? Would you choose to be operated on again if you had to make the decision now? And which procedure do you think you underwent? The first two used a 5-point Likert scale, and the third was a simple yes-or-no question.\u003c\/p\u003e\n\n\u003cp\u003eThe researchers designed the study to detect a \u003cstrong\u003eminimal clinically important improvement\u003c\/strong\u003e of at least 11.5 points on the Lysholm scale, 15.5 points on the WOMET scale, and 2.0 points on the knee pain scale. These thresholds were based on a prospective cohort of 377 patients with degenerative meniscal injury who had undergone arthroscopic partial meniscectomy. To achieve 80% statistical power with a two-sided type 1 error rate of 5%, the required sample sizes were 40, 54, and 40 participants per group for the Lysholm, WOMET, and pain scores, respectively. Anticipating at least 20% loss to follow-up, the researchers planned to enroll 70 patients per group—and they got very close, with 70 and 76 patients, respectively.\u003c\/p\u003e\n\n\u003ch2 id=\"key-findings\"\u003eKey Findings: The Results at 12 Months\u003c\/h2\u003e\n\n\u003cp\u003eHere is the central result: \u003cstrong\u003eboth groups improved dramatically over 12 months, but there was no significant difference between them.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003cp\u003eThe mean improvements in the primary outcomes were as follows:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLysholm score:\u003c\/strong\u003e Improved by 21.7 points in the partial-meniscectomy group versus 23.3 points in the sham-surgery group. The between-group difference was −1.6 points (95% confidence interval [CI], −7.2 to 4.0).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWOMET score:\u003c\/strong\u003e Improved by 24.6 points versus 27.1 points. The between-group difference was −2.5 points (95% CI, −9.2 to 4.1).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eKnee pain after exercise:\u003c\/strong\u003e Improved by 3.1 points versus 3.3 points (on the 0–10 scale). The between-group difference was −0.1 points (95% CI, −0.9 to 0.7).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eTo put these numbers in perspective: a 21.7-point improvement in the Lysholm score represents a substantial clinical benefit. For example, a patient with moderate knee symptoms might go from struggling with stairs and squatting to near-normal function. Patients in both groups experienced exactly this level of improvement—the question is whether the surgery itself caused it or whether it came from the natural course of the condition, the placebo effect, the standardized exercise program, or other factors.\u003c\/p\u003e\n\n\u003cp\u003eThe negative between-group differences mean the sham group actually improved slightly more on all three measures, although these differences were not statistically significant. A 95% confidence interval that crosses zero (as all three do) indicates that the data are compatible with a wide range of possibilities—from the surgery being slightly worse to slightly better—but the most likely interpretation is that there is no meaningful difference.\u003c\/p\u003e\n\n\u003cp\u003eThese results did not materially change even after the researchers adjusted for baseline scores and the stratifying variables used during randomization.\u003c\/p\u003e\n\n\u003ch2 id=\"secondary-outcomes\"\u003eSecondary Outcomes and Safety Results\u003c\/h2\u003e\n\n\u003cp\u003eThe secondary outcomes told the same story. There were \u003cstrong\u003eno significant between-group differences\u003c\/strong\u003e in any of the following:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eKnee pain at rest at 12 months\u003c\/li\u003e\n  \u003cli\u003e15D quality-of-life score at 12 months\u003c\/li\u003e\n  \u003cli\u003eLysholm and WOMET scores at 2 and 6 months (which showed similar improvement trajectories in both groups)\u003c\/li\u003e\n  \u003cli\u003ePatients' satisfaction or subjective improvement ratings\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eSubsequent knee surgery:\u003c\/strong\u003e Two patients in the partial-meniscectomy group required additional knee surgery within 12 months, compared with five patients in the sham-surgery group. This difference was not statistically significant.\u003c\/p\u003e\n\n\u003cp\u003eThe two patients who had subsequent surgery in the real-surgery group are worth examining closely:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eOne patient had a total knee replacement 10 months after the index procedure because of MRI-verified aseptic necrosis (bone death) of the medial femoral condyle—a serious complication, though it is difficult to know whether it was related to the surgery.\u003c\/li\u003e\n  \u003cli\u003eOne patient required a second resection of the meniscus 5 months later because of recurrence of symptoms.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eIn the sham-surgery group, \u003cstrong\u003efive patients had persistent symptoms severe enough that the study-group assignment was revealed\u003c\/strong\u003e (at an average of 8 months after the index operation), and they subsequently underwent additional surgery. This crossover was expected and built into the study design.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSerious adverse events:\u003c\/strong\u003e There was one in the partial-meniscectomy group and zero in the sham-surgery group.\u003c\/p\u003e\n\n\u003cp\u003eA particularly interesting finding concerns patients' guesses about which procedure they received. Patients in the sham-surgery group were \u003cstrong\u003enot\u003c\/strong\u003e significantly more likely than meniscectomy patients to guess they had received the sham procedure: \u003cstrong\u003e47% of sham patients guessed correctly, compared with 38% of surgery patients\u003c\/strong\u003e (P = 0.39). This tells us the blinding worked—patients genuinely could not tell whether they had real surgery or fake surgery, which strengthens confidence in the results.\u003c\/p\u003e\n\n\u003ch2 id=\"subgroup\"\u003eSubgroup Analyses: Did Any Group Benefit?\u003c\/h2\u003e\n\n\u003cp\u003eThe researchers conducted a prespecified subgroup analysis based on the extent of radiographically assessed degenerative changes (Kellgren–Lawrence grade 0, no degeneration, versus grade 1, minor degenerative changes). This was done because knee osteoarthritis has been associated with poor outcomes after knee arthroscopy in previous research.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eNo significant between-group differences were found in either subgroup.\u003c\/strong\u003e There were also no significant interactions by grade, meaning that having minor degenerative changes did not change the conclusion: the surgery was no better than sham regardless of X-ray findings.\u003c\/p\u003e\n\n\u003cp\u003eIn a post hoc (after-the-fact) subgroup analysis, the researchers also looked at patients who reported a sudden onset of symptoms. Even in this subgroup—which might intuitively seem most likely to benefit from surgery—there was \u003cstrong\u003eno significant benefit of arthroscopic partial meniscectomy over sham surgery\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ch2 id=\"limitations\"\u003eStudy Limitations: What This Study Couldn't Prove\u003c\/h2\u003e\n\n\u003cp\u003eWhile this trial was methodologically rigorous, it has limitations that patients should understand:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFollow-up was limited to 12 months.\u003c\/strong\u003e It is possible that differences could emerge (or disappear) over longer time horizons. The sham patients who crossed over to real surgery after 6 to 12 months complicate long-term interpretation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe sham surgery is not exactly the same as \"no treatment.\"\u003c\/strong\u003e Both groups received diagnostic arthroscopy, standardized postoperative care, and a graduated exercise program. The study shows surgery is no better than sham—but both were embedded in a package of care that included exercise instruction and appropriate pain management.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatients with obvious traumatic tears were excluded.\u003c\/strong\u003e The results apply specifically to degenerative meniscal tears, which is actually the most common scenario in the age group studied. The findings should not be extrapolated to younger patients with acute, traumatic meniscal tears—those may be a different disease entirely.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAll patients had no or only minor osteoarthritis (Kellgren–Lawrence grade 0 or 1).\u003c\/strong\u003e The results may not apply to patients with more advanced arthritis.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe study was conducted in Finland.\u003c\/strong\u003e While there is no reason to believe Finnish patients respond differently to knee surgery than patients elsewhere, healthcare systems and expectations vary across countries.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe sample size was modest\u003c\/strong\u003e (146 patients), though it was powered to detect clinically meaningful differences and had zero loss to follow-up.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo per-protocol analysis was performed.\u003c\/strong\u003e However, this was deemed unnecessary because the crossover frequency was low (five sham patients crossed over; two surgery patients had repeat surgery), and the intention-to-treat analysis is actually the more conservative and appropriate approach.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eOne remarkable feature of this study's methodology deserves special mention: the writing committee developed and recorded \u003cstrong\u003etwo interpretations of the results before the randomization code was broken\u003c\/strong\u003e—one assuming treatment A was the real surgery, and another assuming treatment A was the sham. Only after the committee agreed there would be no further changes was the code broken and the correct interpretation selected. This \"blinded interpretation\" strategy protected against bias in how the results were reported.\u003c\/p\u003e\n\n\u003ch2 id=\"clinical-implications\"\u003eClinical Implications: What This Means for Patients\u003c\/h2\u003e\n\n\u003cp\u003eThis study provides the strongest evidence yet that \u003cstrong\u003earthroscopic partial meniscectomy is no better than sham surgery for patients with degenerative meniscal tears without osteoarthritis\u003c\/strong\u003e. The implications are significant because this is one of the most common surgeries in the world.\u003c\/p\u003e\n\n\u003cp\u003eThe findings align with a growing body of evidence. The researchers noted one previous randomized sham-controlled trial of arthroscopic treatment for degenerative knee disease: in patients with established knee osteoarthritis, arthroscopic lavage or debridement did not result in better outcomes than a sham procedure involving only skin incisions. A subsequent trial without a sham control found that arthroscopic surgery combined with optimized physical and medical therapy showed no significant benefit over optimized therapy alone. And a recent trial of arthroscopic partial meniscectomy in patients with meniscal tears and varying degrees of knee osteoarthritis found that surgery plus exercise therapy was not superior to exercise therapy alone.\u003c\/p\u003e\n\n\u003cp\u003eWhat this study adds is crucial: \u003cstrong\u003eeven in patients without osteoarthritis\u003c\/strong\u003e—the group surgeons might most expect to benefit from removing a torn meniscus—the surgery still failed to outperform sham. The widespread belief that removing the torn meniscus is what relieves symptoms is called into question by the fact that patients who had nothing removed improved just as much.\u003c\/p\u003e\n\n\u003cp\u003eSo why do both groups improve? Several explanations are possible:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe placebo effect:\u003c\/strong\u003e The expectation of benefit from surgery can produce real physiological changes, including the release of endorphins and altered pain perception. The fact that only 47% of sham patients correctly guessed their assignment shows the placebo effect was powerful enough to be indistinguishable from real treatment.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNatural history:\u003c\/strong\u003e Degenerative meniscal tears and associated knee pain often improve over time on their own. The median duration of pain at enrollment was 10 months, so these patients had chronic symptoms—yet many improved over the next year regardless of treatment.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe standardized exercise program and postoperative care:\u003c\/strong\u003e Both groups received the same graduated exercise instructions and pain management, which likely contributed to improvement.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe diagnostic arthroscopy itself:\u003c\/strong\u003e Even in the sham group, patients had a camera inserted into the knee and fluid flushed through the joint. Joint lavage and the saline irrigation used during arthroscopy may have some therapeutic effect, though previous sham-controlled trials suggest this is not a durable benefit.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe cost implications are substantial. With 700,000 procedures performed annually in the United States at a direct cost of roughly $4 billion, if even a fraction of these surgeries are unnecessary, the wasted healthcare expenditure is enormous. But more importantly, patients are exposed to the risks of surgery—anesthesia complications, infection, blood clots, and the small but real chance of serious complications like the aseptic necrosis seen in one patient in this trial—without receiving a measurable benefit.\u003c\/p\u003e\n\n\u003ch2 id=\"recommendations\"\u003eRecommendations: What Patients Should Consider\u003c\/h2\u003e\n\n\u003cp\u003eFor patients diagnosed with a degenerative meniscal tear (especially if they are 35 to 65 years old and do not have advanced osteoarthritis), this study offers important guidance:\u003c\/p\u003e\n\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConservative treatment is a reasonable first-line approach.\u003c\/strong\u003e Structured physical therapy, a graduated exercise program, over-the-counter pain relievers, and activity modification have been shown to produce outcomes equivalent to surgery in multiple trials. In this study, both groups received standardized exercise instructions, and both improved equally.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDo not assume surgery is necessary because of an MRI finding.\u003c\/strong\u003e Degenerative meniscal tears are extraordinarily common on MRI in people without any knee symptoms at all. The MRI finding alone is not a reliable predictor of who will benefit from surgery.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHave an informed conversation with your surgeon.\u003c\/strong\u003e Ask specifically: \"Is my meniscal tear degenerative or traumatic?\" \"Do I have osteoarthritis?\" \"What is the evidence that surgery will help me specifically?\" \"What happens if I wait 6 months and try physical therapy first?\"\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConsider shared decision-making.\u003c\/strong\u003e Many patients who strongly prefer to avoid surgery, or who want to exhaust non-surgical options first, may reasonably choose to defer arthroscopy. The sham-controlled evidence shows they are not giving up a proven benefit by doing so.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you do have surgery, be aware of the expectation reality.\u003c\/strong\u003e Both groups improved significantly in this trial, so many patients do feel better after arthroscopy. But the data suggest this improvement is not attributable to the meniscectomy itself. Patients who understand this are less likely to be disappointed and more likely to engage actively in rehabilitation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFor patients with a truly traumatic, mechanical meniscal tear\u003c\/strong\u003e—for example, a sudden twisting injury causing a locked knee that cannot fully straighten—the situation is different. Those patients were excluded from this trial, and mechanical locking is generally considered an indication for surgery. If your knee is mechanically locked, seek prompt orthopedic evaluation.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eThe takeaway is not that arthroscopic meniscectomy is worthless or harmful. It is that, for the most common indication—a degenerative tear without osteoarthritis—the surgery's benefit appears to be no greater than placebo. That knowledge allows patients and doctors to make more informed decisions, potentially avoiding hundreds of thousands of unnecessary surgeries, billions of dollars in healthcare costs, and countless surgical risks, all without sacrificing outcomes.\u003c\/p\u003e\n\n\u003c!-- ddn:faq:start --\u003e\n\u003ch2 id=\"ddn-faq\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWho took part in this knee surgery study?\u003c\/h3\u003e\n\u003cp\u003eResearchers in Finland studied 146 patients aged 35 to 65 with knee pain lasting more than 3 months and a degenerative medial meniscus tear confirmed by arthroscopy. People with osteoarthritis or an obvious traumatic injury were excluded. Both groups had similar average age, weight, and symptom duration at the start.\u003c\/p\u003e\n\u003ch3\u003eWhat were the main results after 12 months?\u003c\/h3\u003e\n\u003cp\u003eBoth groups improved substantially in knee function, pain, and quality of life, but there were no meaningful differences between them. The sham group improved slightly more on all three primary measures, and these differences were not statistically significant. The researchers concluded that real surgery was no better than sham surgery for this patient group.\u003c\/p\u003e\n\u003ch3\u003eDoes this mean arthroscopic knee surgery is never helpful?\u003c\/h3\u003e\n\u003cp\u003eNo. This trial involved only patients with degenerative meniscal tears without osteoarthritis. The results do not apply to younger people with acute traumatic tears, especially those with a mechanically locked knee, which is generally considered a reason for prompt surgical evaluation. For the most common indication studied, however, surgery showed no advantage over sham surgery.\u003c\/p\u003e\n\u003ch3\u003eWhy did both groups improve if the surgery was no better than sham?\u003c\/h3\u003e\n\u003cp\u003eSeveral factors likely contributed: the placebo effect from expecting surgery to help, natural improvement of degenerative tears over time, standardized exercise instructions given to both groups, and possibly the joint lavage during arthroscopy. Blinding was effective, since only 47% of sham patients guessed correctly that they had the sham procedure.\u003c\/p\u003e\n\u003ch3\u003eWhat should I consider if my doctor recommends arthroscopic meniscectomy for a degenerative tear?\u003c\/h3\u003e\n\u003cp\u003eTry structured physical therapy, a graduated exercise program, over-the-counter pain relievers, and activity modification first. Ask whether your tear is degenerative or traumatic and whether you have osteoarthritis. Understand that in this trial, waiting and conservative care led to the same 12-month results as surgery for patients similar to those studied.\u003c\/p\u003e\n\u003ch3\u003eDo I need a second opinion before arthroscopic knee surgery for a degenerative meniscal tear?\u003c\/h3\u003e\n\u003cp\u003eIn a randomized sham-controlled trial, arthroscopic partial meniscectomy was no better than sham surgery for patients with degenerative meniscal tears without osteoarthritis. Both groups improved equally on pain, function, and quality of life. If your surgeon recommends this operation for a degenerative tear, a second opinion can help you determine whether it is truly necessary or whether conservative treatment—such as structured physical therapy and a graduated exercise program—is a reasonable first step. Traumatic tears with mechanical locking were excluded and may require different care. Diagnostic Detectives Network provides independent expert second opinions.\u003c\/p\u003e\n\u003c!-- ddn:faq:end --\u003e\n\n\u003ch2 id=\"source\"\u003eSource Information\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eOriginal article title:\u003c\/strong\u003e Arthroscopic Partial Meniscectomy versus Sham Surgery for a Degenerative Meniscal Tear\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eAuthors:\u003c\/strong\u003e Raine Sihvonen, M.D., Mika Paavola, M.D., Ph.D., Antti Malmivaara, M.D., Ph.D., Ari Itälä, M.D., Ph.D., Antti Joukainen, M.D., Ph.D., Heikki Nurmi, M.D., Juha Kalske, M.D., and Teppo L.N. Järvinen, M.D., Ph.D., for the Finnish Degenerative Meniscal Lesion Study (FIDELITY) Group\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eJournal:\u003c\/strong\u003e The New England Journal of Medicine, December 26, 2013; Volume 369, Issue 26, pages 2515–2524\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDOI:\u003c\/strong\u003e 10.1056\/NEJMoa1305189\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eTrial registration:\u003c\/strong\u003e ClinicalTrials.gov number NCT00549172\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eFunding:\u003c\/strong\u003e Sigrid Juselius Foundation and others\u003c\/p\u003e\n\n\u003cp\u003eThis patient-friendly article is based on peer-reviewed research published in a leading medical journal. It is intended for educational purposes and does not constitute medical advice. Patients should consult their healthcare provider for guidance specific to their individual situation.\u003c\/p\u003e","brand":"DiagnosticDetectives.Com","offers":[{"title":"Default Title","offer_id":47527626211484,"sku":null,"price":0.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/diagnosticdetectives.com\/de\/products\/the-surgery-that-isnt-better-than-a-fake-one-what-a-landmark-knee-meniscus-trial-means-for-patients","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}